PCA Investment Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,031
Closed -$796K 104
2024
Q4
$796K Hold
1,031
0.37% 40
2024
Q3
$914K Sell
1,031
-5
-0.5% -$4.5K 0.43% 39
2024
Q2
$938K Buy
1,036
+21
+2% +$16.8K 0.49% 37
2024
Q1
$790K Buy
1,015
+9
+0.9% +$6.41K 0.44% 40
2023
Q4
$586K Buy
1,006
+69
+7% +$40.3K 0.39% 43
2023
Q3
$504K Hold
937
0.36% 47
2023
Q2
$440K Buy
937
+28
+3% +$11.7K 0.26% 55
2023
Q1
$312K Buy
+909
New +$307K 0.22% 74

Other funds holding LLY

PCA Investment Advisory Services's LLY Position: Q1 2025 in Review

PCA Investment Advisory Services sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 1,031 shares — an estimated $796K sold.

PCA Investment Advisory Services first reported a position in LLY in Q1 2023 and held it in 8 quarters. The position peaked at $938K in Q2 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • PCA Investment Advisory Services reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • PCA Investment Advisory Services sold 1,031 Eli Lilly shares in Q1 2025, an estimated $796K.
  • PCA Investment Advisory Services first reported a position in Eli Lilly in Q1 2023 and held it in 8 quarters.
  • PCA Investment Advisory Services's Eli Lilly position peaked at $938K in Q2 2024.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on PCA Investment Advisory Services's 13F filing for Q1 2025, filed 5 May 2025.